<p><strong>紐約，NY / ACCESS Newswire /2025 年 8 月 10 日/</strong> 如果您在 <strong>RxSight, Inc.</strong> 的投資中遭受了損失，並希望瞭解根據聯邦證券法的潛在賠償，請點擊以下鏈接獲取更多信息：</p>
<p>https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22</p>
<p>或通過電子郵件聯繫 Joseph E. Levi 律師，郵箱地址為 jlevi@levikorsinsky.com，或撥打 (212) 363-7500 與我們經驗豐富的股東倡導團隊聯繫。</p>
<p><strong>訴訟：</strong> 針對 RxSight, Inc.提起了一項集體訴訟，旨在為在 2024 年 11 月 7 日至 2025 年 7 月 8 日期間受到證券欺詐影響的股東追回損失。</p>
<p><strong>案件詳情：</strong> 提起的投訴指控被告發表了虛假陳述和/或隱瞞了以下事實：(1) 公司面臨 “採用挑戰” 和/或結構性問題，導致銷售和使用率下降；(2) 被告誇大了對 RxSight 產品的需求；(3) 因此，RxSight 不太可能達到其之前發佈的 2025 財年的財務指導；(4) 因此，被告對公司業務、運營和前景的積極陳述在實質上具有誤導性和/或缺乏合理依據。</p>
<p><strong>接下來怎麼辦？</strong> 如果您在相關時間段內在 RxSight, Inc.的股票中遭受了損失——即使您仍持有股份——請訪問 https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22 瞭解您尋求賠償的權利。<strong>參與沒有費用或義務。</strong></p>
<p><strong>為什麼選擇 Levi &amp; Korsinsky：</strong> 在過去 20 年中，Levi &amp; Korsinsky LLP 已建立為全國知名的證券訴訟公司，為受害股東爭取了數億美元，並在高風險案件中贏得了良好的記錄。該公司在複雜證券訴訟方面擁有豐富的經驗，並擁有超過 70 名員工為客户服務。連續七年，Levi &amp; Korsinsky 在 ISS 證券集體訴訟服務的前 50 名報告中被評為美國頂級證券訴訟公司之一。律師廣告。以往結果不保證類似結果。</p>
<p><strong>聯繫方式：</strong></p>
<p>Levi &amp; Korsinsky, LLP</p>
<p>Joseph E. Levi, Esq.</p>
<p>Ed Korsinsky, Esq.</p>
<p>33 Whitehall Street, 17th Floor</p>
<p>紐約，NY 10004</p>
<p>jlevi@levikorsinsky.com</p>
<p>電話：(212) 363-7500</p>
<p>傳真：(212) 363-7171</p>
<p>https://zlk.com/</p>
<p><strong>來源：</strong> Levi &amp; Korsinsky, LLP</p>
<p>查看 ACCESS Newswire 上的原始新聞稿</p>

RXST

<p>針對 RxSight, Inc. (RXST) 提起了一項集體訴訟，指控其在 2024 年 11 月 7 日至 2025 年 7 月 8 日期間對股東進行證券欺詐。投訴稱，該公司虛假陳述了其銷售業績，並誇大了產品需求，導致了重大財務損失。遭受損失的股東被鼓勵在 2025 年 9 月 22 日之前聯繫 Levi & Korsinsky LLP 尋求潛在的賠償選項。該律所在證券訴訟方面有着良好的業績記錄，併為受影響的投資者提供無成本參與的機會</p>

<p><strong>NEW YORK, NY / ACCESS Newswire / August 10, 2025 /</strong> If you suffered a loss on your <strong>RxSight, Inc.</strong> investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:</p>
<div class="lb-trans"><p><strong>紐約，NY / ACCESS Newswire /2025 年 8 月 10 日/</strong> 如果您在 <strong>RxSight, Inc.</strong> 的投資中遭受了損失，並希望瞭解根據聯邦證券法的潛在賠償，請點擊以下鏈接獲取更多信息：</p>
</div><p>https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22</p>
<div class="lb-trans"><p>https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22</p>
</div><p>or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.</p>
<div class="lb-trans"><p>或通過電子郵件聯繫 Joseph E. Levi 律師，郵箱地址為 jlevi@levikorsinsky.com，或撥打 (212) 363-7500 與我們經驗豐富的股東倡導團隊聯繫。</p>
</div><p><strong>THE LAWSUIT:</strong> A class action securities lawsuit was filed against RxSight, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between November 7, 2024 and July 8, 2025.</p>
<div class="lb-trans"><p><strong>訴訟：</strong> 針對 RxSight, Inc.提起了一項集體訴訟，旨在為在 2024 年 11 月 7 日至 2025 年 7 月 8 日期間受到證券欺詐影響的股東追回損失。</p>
</div><p><strong>CASE DETAILS:</strong> The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company was experiencing &#34;adoption challenges&#34; and/or structural issues resulting in declines in sales and utilization; (2) defendants had overstated the demand for RxSight's products; (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (4) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.</p>
<div class="lb-trans"><p><strong>案件詳情：</strong> 提起的投訴指控被告發表了虛假陳述和/或隱瞞了以下事實：(1) 公司面臨 “採用挑戰” 和/或結構性問題，導致銷售和使用率下降；(2) 被告誇大了對 RxSight 產品的需求；(3) 因此，RxSight 不太可能達到其之前發佈的 2025 財年的財務指導；(4) 因此，被告對公司業務、運營和前景的積極陳述在實質上具有誤導性和/或缺乏合理依據。</p>
</div><p><strong>WHAT'S NEXT?</strong> If you suffered a loss in RxSight, Inc. stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22 to learn about your rights to seek a recovery. <strong>There is no cost or obligation to participate.</strong></p>
<div class="lb-trans"><p><strong>接下來怎麼辦？</strong> 如果您在相關時間段內在 RxSight, Inc.的股票中遭受了損失——即使您仍持有股份——請訪問 https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22 瞭解您尋求賠償的權利。<strong>參與沒有費用或義務。</strong></p>
</div><p><strong>WHY LEVI &amp; KORSINSKY:</strong> Over the past 20 years, Levi &amp; Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p><strong>為什麼選擇 Levi &amp; Korsinsky：</strong> 在過去 20 年中，Levi &amp; Korsinsky LLP 已建立為全國知名的證券訴訟公司，為受害股東爭取了數億美元，並在高風險案件中贏得了良好的記錄。該公司在複雜證券訴訟方面擁有豐富的經驗，並擁有超過 70 名員工為客户服務。連續七年，Levi &amp; Korsinsky 在 ISS 證券集體訴訟服務的前 50 名報告中被評為美國頂級證券訴訟公司之一。律師廣告。以往結果不保證類似結果。</p>
</div><p><strong>CONTACT:</strong></p>
<div class="lb-trans"><p><strong>聯繫方式：</strong></p>
</div><p>Levi &amp; Korsinsky, LLP</p>
<div class="lb-trans"><p>Levi &amp; Korsinsky, LLP</p>
</div><p>Joseph E. Levi, Esq.</p>
<div class="lb-trans"><p>Joseph E. Levi, Esq.</p>
</div><p>Ed Korsinsky, Esq.</p>
<div class="lb-trans"><p>Ed Korsinsky, Esq.</p>
</div><p>33 Whitehall Street, 17th Floor</p>
<div class="lb-trans"><p>33 Whitehall Street, 17th Floor</p>
</div><p>New York, NY 10004</p>
<div class="lb-trans"><p>紐約，NY 10004</p>
</div><p>jlevi@levikorsinsky.com</p>
<div class="lb-trans"><p>jlevi@levikorsinsky.com</p>
</div><p>Tel: (212) 363-7500</p>
<div class="lb-trans"><p>電話：(212) 363-7500</p>
</div><p>Fax: (212) 363-7171</p>
<div class="lb-trans"><p>傳真：(212) 363-7171</p>
</div><p>https://zlk.com/</p>
<div class="lb-trans"><p>https://zlk.com/</p>
</div><p><strong>SOURCE:</strong> Levi &amp; Korsinsky, LLP</p>
<div class="lb-trans"><p><strong>來源：</strong> Levi &amp; Korsinsky, LLP</p>
</div><p>View the original press release on ACCESS Newswire</p>
<div class="lb-trans"><p>查看 ACCESS Newswire 上的原始新聞稿</p>
</div>

在 RxSight, Inc. (RXST) 上虧損？被敦促在2025年9月22日前加入集體訴訟 - 請聯繫 Levi & Korsinsky